Astellas to Present VEOZA™ (fezolinetant) Data at IMS World Congress on Menopause ...Middle East

TOKYO, Oct. 10, 2024 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") announced that VEOZA™ (fezolinetant)*, its first-in-class treatment for moderate to severe vasomotor symptoms (VMS) associated with menopause, will be featured in four oral...

Hence then, the article about astellas to present veoza fezolinetant data at ims world congress on menopause was published today ( Thursday 10/10/2024 - 10:04 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Astellas to Present VEOZA™ (fezolinetant) Data at IMS World Congress on Menopause )

Also on site :

• Travis County deputy arrested on official oppression charge
• 10 Shows Like 'Your Friends and Neighbors' You Should Watch Next
• Republicans Flirt With Kicking Americans Off Health Care to Fund Iran War